Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference

Jinmin Lee, Victoria P. Werth, Russell P. Hall, Rüdiger Eming, Janet A. Fairley, David C. Fajgenbaum, Karen E. Harman, Marcel F. Jonkman, Neil J. Korman, Ralf J. Ludwig, Dedee F. Murrell, Philippe Musette, Haley B. Naik, Christian D. Sadik, Jun Yamagami, Marc L. Yale, Aimee S. Payne

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The 5th Scientific Conference of the International Pemphigus and Pemphigoid Foundation (IPPF), "Pemphigus and Pemphigoid: A New Era of Clinical and Translational Science" was held in Orlando, Florida, on May 15-16, 2018. Scientific sessions covered recent, ongoing, and future clinical trials in pemphigus and bullous pemphigoid, disease activity and quality of life instruments, and the IPPF Natural History Study. Furthermore, the meeting provided an opportunity to hear firsthand from patients, investigators, and industry about their experience enrolling for clinical trials.

Original languageEnglish
Article number00306
JournalFrontiers in Medicine
Volume5
Issue numberNOV
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Bullous Pemphigoid
Internationality
Pemphigus
Clinical Trials
Natural History
Industry
Quality of Life
Research Personnel

Keywords

  • Btk
  • Doxycycline
  • Eotaxin
  • FcRn
  • Fumarate
  • Leukotriene
  • Rituximab
  • T-cell

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lee, J., Werth, V. P., Hall, R. P., Eming, R., Fairley, J. A., Fajgenbaum, D. C., ... Payne, A. S. (2018). Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference. Frontiers in Medicine, 5(NOV), [00306]. https://doi.org/10.3389/fmed.2018.00306

Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference. / Lee, Jinmin; Werth, Victoria P.; Hall, Russell P.; Eming, Rüdiger; Fairley, Janet A.; Fajgenbaum, David C.; Harman, Karen E.; Jonkman, Marcel F.; Korman, Neil J.; Ludwig, Ralf J.; Murrell, Dedee F.; Musette, Philippe; Naik, Haley B.; Sadik, Christian D.; Yamagami, Jun; Yale, Marc L.; Payne, Aimee S.

In: Frontiers in Medicine, Vol. 5, No. NOV, 00306, 01.01.2018.

Research output: Contribution to journalArticle

Lee, J, Werth, VP, Hall, RP, Eming, R, Fairley, JA, Fajgenbaum, DC, Harman, KE, Jonkman, MF, Korman, NJ, Ludwig, RJ, Murrell, DF, Musette, P, Naik, HB, Sadik, CD, Yamagami, J, Yale, ML & Payne, AS 2018, 'Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference', Frontiers in Medicine, vol. 5, no. NOV, 00306. https://doi.org/10.3389/fmed.2018.00306
Lee, Jinmin ; Werth, Victoria P. ; Hall, Russell P. ; Eming, Rüdiger ; Fairley, Janet A. ; Fajgenbaum, David C. ; Harman, Karen E. ; Jonkman, Marcel F. ; Korman, Neil J. ; Ludwig, Ralf J. ; Murrell, Dedee F. ; Musette, Philippe ; Naik, Haley B. ; Sadik, Christian D. ; Yamagami, Jun ; Yale, Marc L. ; Payne, Aimee S. / Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference. In: Frontiers in Medicine. 2018 ; Vol. 5, No. NOV.
@article{55989fe607a44c56bcd26118e9bdba9e,
title = "Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference",
abstract = "The 5th Scientific Conference of the International Pemphigus and Pemphigoid Foundation (IPPF), {"}Pemphigus and Pemphigoid: A New Era of Clinical and Translational Science{"} was held in Orlando, Florida, on May 15-16, 2018. Scientific sessions covered recent, ongoing, and future clinical trials in pemphigus and bullous pemphigoid, disease activity and quality of life instruments, and the IPPF Natural History Study. Furthermore, the meeting provided an opportunity to hear firsthand from patients, investigators, and industry about their experience enrolling for clinical trials.",
keywords = "Btk, Doxycycline, Eotaxin, FcRn, Fumarate, Leukotriene, Rituximab, T-cell",
author = "Jinmin Lee and Werth, {Victoria P.} and Hall, {Russell P.} and R{\"u}diger Eming and Fairley, {Janet A.} and Fajgenbaum, {David C.} and Harman, {Karen E.} and Jonkman, {Marcel F.} and Korman, {Neil J.} and Ludwig, {Ralf J.} and Murrell, {Dedee F.} and Philippe Musette and Naik, {Haley B.} and Sadik, {Christian D.} and Jun Yamagami and Yale, {Marc L.} and Payne, {Aimee S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.3389/fmed.2018.00306",
language = "English",
volume = "5",
journal = "Frontiers in Medicine",
issn = "2296-858X",
publisher = "Frontiers Media S. A.",
number = "NOV",

}

TY - JOUR

T1 - Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference

AU - Lee, Jinmin

AU - Werth, Victoria P.

AU - Hall, Russell P.

AU - Eming, Rüdiger

AU - Fairley, Janet A.

AU - Fajgenbaum, David C.

AU - Harman, Karen E.

AU - Jonkman, Marcel F.

AU - Korman, Neil J.

AU - Ludwig, Ralf J.

AU - Murrell, Dedee F.

AU - Musette, Philippe

AU - Naik, Haley B.

AU - Sadik, Christian D.

AU - Yamagami, Jun

AU - Yale, Marc L.

AU - Payne, Aimee S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The 5th Scientific Conference of the International Pemphigus and Pemphigoid Foundation (IPPF), "Pemphigus and Pemphigoid: A New Era of Clinical and Translational Science" was held in Orlando, Florida, on May 15-16, 2018. Scientific sessions covered recent, ongoing, and future clinical trials in pemphigus and bullous pemphigoid, disease activity and quality of life instruments, and the IPPF Natural History Study. Furthermore, the meeting provided an opportunity to hear firsthand from patients, investigators, and industry about their experience enrolling for clinical trials.

AB - The 5th Scientific Conference of the International Pemphigus and Pemphigoid Foundation (IPPF), "Pemphigus and Pemphigoid: A New Era of Clinical and Translational Science" was held in Orlando, Florida, on May 15-16, 2018. Scientific sessions covered recent, ongoing, and future clinical trials in pemphigus and bullous pemphigoid, disease activity and quality of life instruments, and the IPPF Natural History Study. Furthermore, the meeting provided an opportunity to hear firsthand from patients, investigators, and industry about their experience enrolling for clinical trials.

KW - Btk

KW - Doxycycline

KW - Eotaxin

KW - FcRn

KW - Fumarate

KW - Leukotriene

KW - Rituximab

KW - T-cell

UR - http://www.scopus.com/inward/record.url?scp=85061386336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061386336&partnerID=8YFLogxK

U2 - 10.3389/fmed.2018.00306

DO - 10.3389/fmed.2018.00306

M3 - Article

AN - SCOPUS:85061386336

VL - 5

JO - Frontiers in Medicine

JF - Frontiers in Medicine

SN - 2296-858X

IS - NOV

M1 - 00306

ER -